Revolutionary Changes in Hematology Therapies
PR Newswire (press release) - New York,NY,USA
... LS-104 (Aegera), Torisel (Wyeth), Bexxar (GSK), Zevalin (Biogen/Idec), ofatumumab (Genmab/GSK), SGN-40 (Seattle Genetics / Genentech), MyVax (Genitope), ...
See all stories on this topic